The "TETRAVARINEX" trademark, serial number 79132921 , was filed on 30th of May 2013 with a mark drawing code of 4000 and its transaction date is 79132921. The attorney assigned is Michelle L. Visser, attorney docket number 66569-0032. Since 24th of March 2014, the document can be found in the L20 law office in the publication and issue section. The status of this trademark was checked last on 03/24/2014.

Prior registrations: 3423146 , 4366677

The corresponded responsible for this trademark is Michelle L. Visser, located at Rader, Fishman & Grauer PLLC, 39533 Woodward Ave., Ste. 140, Bloomfield Hills MI 48304.

The state or country where the trademark was organized is by Gw Pharma Limited. The legal entity type behing it is a Corporation, located at Salisbury, Wiltshire Sp4 0jq, , zip .Other trademarks by this applicant: CANNABIDEX.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class	052 - Detergents and Soaps
Class Status	6 - Active
Status Date	07/22/2013
Primary Code	005
Goods codes
GS0051	Pharmaceutical and veterinary pharmaceutical preparations, namely, herbs, herbal extracts, formulas containing herbal extracts, medicinal oils and pure extracts of medicinal plants and herbs, for use in the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, epilepsy, dravet syndrome, neonatal hypoxia, seizures, alzheimers, bone disorders, drug, alcohol and nicotine abuse, inflammatory disorders, protection of pancreatic islet cells in the treatment of diabetic or pre-diabetic patients, protection of beta cells in the treatment of diabetic or pre-diabetic patients, maintenance of insulin levels, improved control of blood glucose levels, treatment of type I diabetes, treatment of type II diabetes ; pharmaceutical and veterinary pharmaceutical preparations for the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, epilepsy, dravet syndrome, neonatal hypoxia, seizures, alzheimers, bone disorders, drug, alcohol and nicotine abuse, inflammatory disorders, protection of pancreatic islet cells in the treatment of diabetic or pre-diabetic patients, protection of beta cells in the treatment of diabetic or pre-diabetic patients, maintenance of insulin levels, improved control of blood glucose levels, treatment of type I diabetes, treatment of type II diabetes; herbs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes

INTERNATIONAL REGISTRATION
International Registration Number	0918111
International Registration Date	11/20/2006
International Publication Date	07/25/2013
International Renewal Date	11/20/2016
Auto protection	01/18/2015
International Status Code	001 - Request for extension of protection established
International Status Date	07/18/2013
Priority Claimed In	No
First Refusal In	Yes

PROSECUTION HISTORY
Date	Description	Type	Code
03/24/2014	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2014	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2014	TEAS RESPONSE TO OFFICE ACTION RECEIVED	I - Incoming Correspondence	TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/02/2014	ATTORNEY REVOKED AND/OR APPOINTED	I - Incoming Correspondence	ARAA - ATTORNEY REVOKED AND/OR APPOINTED
01/02/2014	TEAS REVOKE/APPOINT ATTORNEY RECEIVED	I - Incoming Correspondence	REAP - TEAS REVOKE/APPOINT ATTORNEY RECEIVED
10/20/2013	REFUSAL PROCESSED BY IB	P	RFNT - REFUSAL PROCESSED BY IB
09/25/2013	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	P	RFCS - REFUSAL SENT TO IB
09/25/2013	REFUSAL PROCESSED BY MPU	P	RFRR
09/24/2013	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	E	RFCR - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/23/2013	NON-FINAL ACTION WRITTEN	R - Renewal	CNRT - NON-FINAL ACTION WRITTEN
09/15/2013	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
07/26/2013	APPLICATION FILING RECEIPT MAILED	O - Outgoing Correspondence	MAFR
07/22/2013	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
07/18/2013	SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB	M	SDRC - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.